Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 26 Jun 2025 for Candel Therapeutics, Inc., €21k.
Filing timeline
BuySaleCharles Schoch
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Charles Schoch: trading record in brief
This profile gathers the share dealings of Charles Schoch in Candel Therapeutics, Inc. We count 6 filings; the first trade dates from 11 July 2024 and the latest from 25 June 2025.
Every open-market trade on record is a sale: 5 sales worth €294k. Besides market trades, the filings include 1 share grant. In 2025 alone, the filings show no purchases and 3 sales.
The latest filing, published on 26 June 2025, reports a share grant of €21k in Candel Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles Schoch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
5,353 shares@ US$4.676.8% of flowCommon StockSEC:0000950170-25-090193:0
5,000 shares@ US$8.833812.9% of flowCommon StockSEC:0000950170-25-041991:0
9,511 shares@ US$7.22521.2% of flowCommon StockSEC:0000950170-25-006725:0
9,971 shares@ US$8.218225.1% of flowCommon StockSEC:0000950170-25-004199:0
9,884 shares@ US$6.472618.6% of flowCommon StockSEC:0000950170-24-084760:0
8,897 shares@ US$5.973415.5% of flowCommon StockSEC:0000950170-24-083399:0
6 of 6 declarations
